In addition, we examined the role of rosiglitazone in TGF-β1-induced ECM expression in human ADPKD cyst-lining epithelia and investigated the underlying molecular mechanisms. This evidence concerns the gene TGFB1 and autosomal dominant polycystic kidney disease.